G eneral anesthetics, such as the inhaled drug isoflurane, are recognized and valued for their critical hypnotic actions in rendering patients unconscious during surgery. However, along with their acute effects studies have revealed that general anesthetics can also result in long-term changes (hours-weeks postexposure) in cellular and tissue function 1-3 resulting in either detrimental or potentially protective outcomes. Indeed, it is now well documented that even brief exposures to anesthetic drugs can have profound and lasting effects on gene expression in multiple tissues. [4] [5] [6] For instance, Sergeev et al. 7 demonstrated in the heart that exposures to isoflurane triggered changes in the regulation of multiple genes involved in both cellular protection and damage, and discussed the former in relation to their potential roles in anesthetic preconditioning (APC) protection.
Preconditioning is a biological phenomenon whereby nonlethal stressors, including brief bouts of ischemia 8 or drugs such as volatile anesthetics, 9, 10 are able to regulate endogenous pathways that can protect against subsequent, potentially lethal ischemia. Protection derived through preconditioning is typically biphasic. Early preconditioning (lasting 2-3 hours) relies on rapid, posttranslational modifications to existing proteins and begins almost immediately after application of the preconditioning stimulus. 11 By contrast, delayed preconditioning relies on de novo protein synthesis and has an extended protective window that begins 12 to 24 hours poststimulus, and lasts up to 96 hours in vivo. 12 Delayed preconditioning has been shown to provide protection against acute ischemic injury in a range of tissues including brain and heart in a number of in vivo and in vitro models. 9, 10, [13] [14] [15] [16] Furthermore, delayed APC can also provide improved long-term neurological and histological outcomes after cerebral ischemic injury. 17 Given the potential for both widespread protection from ischemic injury along with the relative safety of administering APC, 18 there is substantial interest in understanding the molecular mechanisms through which APC arises. 19, 20 Multiple pathways have been identified in APC that involve cyclooxygenase-2, 21 nuclear factor kappa B, 22 PI3 kinase, 23 adenosine triphosphate (ATP)-sensitive potassium channels, 24 manganese superoxide dismutase, 25 12-lipoxygenase, 26 and nitric oxide. 20 Nevertheless, a comprehensive picture of how anesthetics induce protection has yet to be described. In the current study, we aimed to generate a focused list of genes that might potentially play a role in the induction of delayed APC. To accomplish this, we used DNA microarray to identify anesthetic-regulated genes 27 at an early window after anesthetic exposure. To analyze the BACKGROUND: Although general anesthetics are recognized for their potential to render patients unconscious during surgery, exposure can also lead to long-term outcomes of both cellular damage and protection. As regards the latter, delayed anesthetic preconditioning is an evolutionarily conserved physiological response that has the potential for protecting against ischemic injury in a number of tissues. Although it is known that delayed preconditioning requires de novo protein synthesis, knowledge of anesthetic-regulated genes is incomplete. In this study, we used the conserved nature of preconditioning to analyze differentially regulated genes in 3 different rat tissues. We hypothesized that by selecting those genes regulated in multiple tissues, we could develop a focused list of gene candidates potentially involved in delayed anesthetic preconditioning. METHODS: Young adult male Sprague-Dawley rats were anesthetized with a 2% isoflurane/98% air mixture for 90 minutes. Immediately after anesthetic exposure, animals were euthanized and liver, kidney, and heart were removed and total RNA was isolated. Differential gene expression was determined using rat oligonucleotide gene arrays. Array data were analyzed to select for genes that were significantly regulated in multiple tissues. RESULTS: All 3 tissues showed differentially regulated genes in response to a clinically relevant exposure to isoflurane. Analysis of coordinately regulated genes yielded a focused list of 34 potential gene candidates with a range of ontologies including regulation of inflammation, modulation of apoptosis, regulation of ion gradients, and maintenance of energy pathways. CONCLUSIONS: Through using an analysis approach focusing on coordinately regulated genes, we were able to generate a focused list of interesting gene candidates with potential to enable future preconditioning studies. (Anesth Analg 2013;116:589-95)
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Analysis of Isoflurane-Mediated Changes to Gene Expression regulated genes and to identify those that might be involved in APC, we used a novel approach in which we capitalized on the observation that delayed APC is conserved across a wide range of organisms (mouse, 1 rat, 9 rabbit, 10 and human 16 ) and tissues (heart, 10 brain, 9 skeletal muscle, 28 kidney, 27 and spinal chord 22 ). Indeed, APC has even been shown to extend beyond vertebrates to Caenorhabditis elegans. 29, 30 By filtering our data to select for genes regulated in multiple tissues, we generated a focused list of genes coordinately regulated in response to isoflurane exposure.
METHODS

Animal Care
Animals were housed, and all experiments were performed with protocols approved by Smith College Institutional Animal Care and Use Committee (Northampton, MA) according to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, 1996). Male Sprague-Dawley rats were acquired from Jackson Laboratories (250 and 300 g; Bar Harbor, ME) and allowed to acclimatize for 2 weeks before experiments. Animals were maintained under a standard 12/12 light/dark cycle at room temperature and given access to food and water ad libitum.
Arrays
Rat-specific DNA microarrays were obtained from the Rutgers Neuronal Gene expression Lab (Piscataway, NJ). Briefly, each array was constructed from a collection of 4967 probes representing approximately 4900 genes printed onto poly-l-lysine slides. Probes were 65 to 70 nucleotides in length and were designed to optimize melting temperature and to minimize homology between probes. Further information about these arrays can be found at the Web site http://www.cag.icph.org/microarray_facility.htm.
Isoflurane Exposure and Tissue Collection
Animals receiving isoflurane treatment were placed in an induction chamber and induced with 3% isoflurane/97% medical grade air (vol/vol) until loss of righting reflex (2-3 minutes). Anesthesia was then maintained at 2% isoflurane/98% air (approximately 1.5 minimal alveolar concentration) for the remainder of the 90-minute exposure period. Body temperature was maintained at 37°C throughout the treatment using heated gel packs and oxygen levels were monitored using a model V3304 pulse oximeter (Surgivet, Waukesha, WI). Oxygen saturation levels were observed to be >95% at all times. On completion of the anesthetic exposure, test animals were immediately decapitated. Samples from liver, kidney cortex, and heart ventricle were collected and homogenized with a Polytron homogenizer (Brinkmann, Westbury, NY) in ice cold Trizol (Invitrogen, Carlsbad, CA). Since stress has been demonstrated to influence gene expression, 31 control animals were maintained in their cages until the time of euthanization. Each control animal was handled gently and then rapidly decapitated. Tissue was processed in the same manner as for test animals. Tissue/Trizol homogenates were stored at -20°C until further processing. All animals were euthanized during the same daily 5-hour window to diminish confounding factors from diurnal variations in gene expression. 32 
RNA Preparation
Total RNA was isolated from Trizol/tissue homogenate by adding chloroform and performing a phase extraction. The aqueous phase was mixed with ethanol 1:3 v/v and added to an RNeasy column (Qiagen, Valencia, CA). Manufacturer's instructions were followed for column washing and elution of RNA. Purified RNA was quantified using a Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies, Rockland, DE). All samples yielded A 260 /A 280 ratios between 1.9 and 2.1. Isolated RNA was stored at -80°C until further use. The same RNA preparations were used for both microarray experiments and subsequent quantitative reverse-transcriptase polymerase chain reaction (QRT-PCR) verification of selected genes.
Experimental Design
For each tissue, cDNA generated from an individual isoflurane-treated animal was competitively hybridized against control cDNA generated from a pool composed of equal amounts of RNA from 8 control individuals. 33 For each tissue from an individual, the array processing was performed twice using the same labeling schema, and a third time reversing the labeling schema as a dye-flip control to ensure no dye-specific artifacts. Three slides were repeated for each of 3 experimental animals, for a total of 9 arrays per tissue.
Target Labeling and Hybridization
Microarray targets were prepared using the Genisphere 350 dendrimer labeling system according to the manufacturer's instructions (Genisphere, Inc., Hatfield, PA). 34 Briefly, 2.5 µg of isoflurane-treated and pooled control RNA were reversetranscribed to cDNA in separate tubes using Superscript II (Invitrogen), and oligo d(T) 18 primers containing unique, label-specific capture sequences. Samples were then alkaline hydrolyzed to destroy residual RNA. Control and testtagged cDNAs were mixed, applied to arrays, and sealed in watertight chambers (GeneMachines, Ann Arbor, MI), and allowed to hybridize for 48 to 72 hours in a water bath at 55°C. Arrays were washed 1 time for 10 minutes (2× SSC, 55°C), followed by 2 washes for 10 minutes (0.2× SSC, room temperature). Arrays were then spin-dried before labeling. Hybridized arrays were labeled with fluorescent-labeled dendrimer and incubated 2 hours at 61°C. Labeled arrays were washed and dried as described above and scanned using an Axon GenePix 4100 scanner and GenePix 4.0 software (Axon Instruments, Union City, CA).
Data Analysis
Scanned array images were processed using Genepix 4.0 (Axon Instruments). Spots were eliminated if the signal to noise ratio of the spot decreased below 2.0. Statistical analysis of each tissue group was performed using G-Processor (version 3.1, Zhong Guan, http://bioinformatics.med.yale. edu). This analysis package performs a Lowess normalization 33 and yields a differential expression ratio along with a Student t test P value for each probe. For each tissue, the gene list was screened for statistical significance in Excel (Microsoft, Redmond, WA) using the following 3 criteria for each gene selected: P ≤ 0.05, spot data valid for ≥7 of the 9 arrays, and levels of differential expression ≥1.2 compared with control. The final list of "interesting genes" was compiled by choosing genes that were differentially expressed in more than 1 tissue and whose expression pattern (both up or both down) was consistent among the different tissues.
QRT-PCR
To verify results from our microarray, 3 of the highly regulated genes from the liver arrays were selected for verification by QRT-PCR (Table 1 for primer and probe sequences). All primer/probe sets were acquired from Integrated DNA technologies Inc. (Coralville, IA). Each QRT-PCR reaction was performed in a single tube on an Applied Biosystems 7700 "TaqMan" instrument (Applied Biosystems Inc., Foster City, CA). The QRT-PCR reaction mix was composed of 1× PCR buffer (Invitrogen), 6 mM MgCl 2 , 0.67 mM each dinucleotide, 6.75 pmols each of forward and reverse primers, 100 nM FAM/TAMRA probe, 1.5 units Superase-in (Ambion, Austin, TX), 15 units Superscript II (Invitrogen), 0.75 units Platinum Taq Polymerase (Invitrogen) to a final volume of 15 µL. Each reaction was run 1 cycle of 30′ at 42°, 1 cycle of 3′ at 95°, and 40 cycles of 1′ at 60° and 20′′ at 95°. Universal mouse RNA (Stratagene, La Jolla, CA) was used to create a standard curve for each gene of interest and for the normalization gene. Gene reactions were run in triplicate, averaged, and normalized to rat protein tyrosine phosphatase, receptor type C, a gene that was chosen for the normalization because it showed no differential regulation on any of the tissue arrays.
RESULTS
On the basis of our selection criteria, all of the tissues tested showed differential gene expression in response to a 90-minute treatment with 2.0% isoflurane. Liver showed the greatest number of differentially regulated genes in response to isoflurane exposure with 725 of 4900 (~15%) genes showing significant upregulation and downregulation, which was more than 1.2-fold as compared with the pooled control. Kidney had fewer anesthetic-regulated genes with 214 (~4%) and heart had the least with 137 (~3%).
Of the genes described above, 34 of the 4937 genes on the arrays were differentially regulated in the same direction in at least 2 tissues ( Table 2 for gene descriptions). Of these, 19 were upregulated and 15 were downregulated. Figure 1 shows a Venn diagram of the distribution of the 34 coregulated genes. From the genes described in Table 2 , a number of ontologies were represented including: apoptosis, necrosis and survival signaling, regulation of energetic pathways, modulation of cellular redox, maintenance of cellular ion gradients, regulation of inflammatory response, and regulation of vesicular transport. We selected 3 of the genes (metallothionein II, peroxiredoxin 5, and cyclin D1) that were significantly regulated on the liver arrays and assessed their expression levels by QRT-PCR using the same RNA as for the array experiments. As shown in Figure 2 , there was agreement between the microarray and QRT-PCR differential expression levels, confirming the validity of the arrays for determining differential expression levels under the selected conditions.
DISCUSSION
In the current study, we exposed male Wistar rats to clinical levels of the anesthetic isoflurane and assessed changes to gene expression in rat liver, kidney, and heart at an early time point after anesthetic exposure. From our array analyses, we identified approximately 1000 rat genes whose expression was significantly impacted by a 90-minute isoflurane exposure. Given the role of the liver in detoxification and metabolism, it is not surprising that the majority of these candidates were identified in liver compared with kidney and heart. Nevertheless, pronounced anestheticinduced changes in gene expression suggest that isoflurane has an enduring impact on cellular function and metabolism postexposure. On assessing the ontologies of the coregulated transcripts from multiple tissues, it was particularly striking that genes related to apoptosis, cell survival, energy pathways, cellular redox, and inflammation were highly represented. These findings support the notion that genes coregulated by isoflurane in multiple tissues may be important to evolutionarily conserved physiological phenomena like APC.
Although research on delayed APC has illuminated a number of the mechanisms involved in providing protection, a complete picture of the genetic pathways involved in the induction of APC has yet to emerge. By using a novel approach to analyze microarray data from multiple exposed tissues, we generated a list of 34 differentially regulated genes (<1% of the total) that are potentially involved in conserved pathways like preconditioning. Although some of the genes from our list have been reported to be involved in APC, including interferon regulatory factor 1 (Irf1) 35 and voltage-dependent anion channel 2 (VDAC2), 36 a number of the genes on our focused list have not previously been described.
In support of our view that some of these genes may be involved in conferring APC, we reported a functional study of 2 of the genes from our list, metallothioneins I + II 
GAAGCAGAGGGCAAAGTGGATGT CTATGG
All sequences shown are 5'-3'. Probes sequences were modified with a 5' 6-carboxy fluorescein and at the 3' end with a 6-carboxy-tetramethyl rhodamine. Primers and probes were designed in Primer express 1.0 (Applied Biosystems Inc.)
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Analysis of Isoflurane-Mediated Changes to Gene Expression (MT-I/II). 1 Using an in vitro model of ischemic brain injury, we found MTs play an important role in isoflurane-mediated APC. 1 Due to heterogeneity of the tissue, we did not explore anesthetic-induced global changes in gene expression in brain in the present study. Nevertheless, we have previously shown that MT I and II were upregulated in response to isoflurane exposure in mixed neural cultures.
In addition to the metallothioneins, a number of the other genes in the list have described functions that make them interesting candidates for participating in delayed APCmediated protection.
Five of the genes we identified (Vdac2, BAD, Pld1, Slc25a3, Atp1a1) are broadly involved in apoptosis, necrosis, and survival signaling. VDAC2 is a mitochondrial outer membrane protein. It is a component of the mitochondrial permeability transition pore that participates in transportation of metabolites and helps regulate cellular progression toward apoptosis. 37 VDAC2 has also been suggested to participate in APC. 11 VDAC2 activity is regulated, at least in part, by another in the gene list, Bcl2associated death agonist (BAD). 37 BAD has been found to be modulated during early ischemic preconditioning and APC, 38, 39 although to our knowledge differential regulation of BAD has not been associated with anesthetic exposure.
Phospholipase D1 is a pleiotropic protein whose cleavage by caspases has been reported to promote apoptosis via Selected genes had to be present on at least 7 of 9 arrays, found to have statistically significant (P ≤ 0.05) differential regulation compared with a pooled control in at least 2 separate tissues, and be regulated at least 1.2 either both up or both down in each of those tissues. NA = not applicable; EGF = epidermal growth factor; EMMPRIN = extracellular matrix metalloprotein inducer; UDP = uridine diphosphate; NSR = no significant regulation.
a p53-dependent pathway. 40 Its activity during ischemiareperfusion has also been tied to signaling for necrotic death. 41 Solute carrier family 25, member 3 (Slc25a3) is another pleiotropic protein that has been reported to be a regulator of mitochondrial cytochrome-c release (a protein important for caspase-dependent apoptosis). 42 The ATPase, Na + /K + transporting α1 polypeptide (Atpa1), is the catalytic subunit of a membrane bound Na + /K + transporter ATPase. Na + /K + ATPases have been shown to have roles in survival signaling. 43 Disruption of Na + , K + , and Ca 2+ ion gradients is an important step in the progression of ischemia-reperfusion injury. 44 Two of the genes above (Pld1 and Atpa1) have described roles in the regulation of cellular Ca 2+ and Na + and K + ion gradients, respectively. 41, 45 Pld1 is a membrane protein that is involved in sarcolemmal Ca 2+ control in heart and skeletal muscle. 41 Atpa1 is an integral membrane protein that is essential for establishing and maintaining Na + and K + gradients across the plasma membrane. Disregulation of Na + /K + ATPases and the resultant loss of membrane potential is a central feature of the ischemic cascade and accompanying excitotoxicity. 46 Inflammatory responses can play a significant role in later stages of ischemic injury. 46 Two of the genes we identified, Irf1 and basigin have been reported to participate in inflammatory response. 47, 48 Irf1 regulates the transcription of interferons α and β and acts as a transcriptional regulator of genes controlled by these interferons. 13 Knockout of Irf1 was shown to improve outcomes in a mouse model of ischemic stroke. 47, 49 Basigin, also known as extracellular matrix metalloprotein inducer (EMMPRIN), has been reported to have a role in modulating an inflammatory response. 48 Additionally, basigin has been implicated in both diminished and improved outcomes after ischemic damage independent of its role in inflammation. Its role in tissue remodeling after ischemic damage in rat heart 50 and brain 51 has been associated with negative outcomes. However, basigin has also been associated with improved outcomes during hypoxia and ischemia through protection against lactic acid damage in neuronal and cardiac tissue. 52, 53 Additionally, complexed with cyclophilin A, basigin has been reported to protect neurons from ischemic and oxidative stress. 54 Disruption of energy pathways is key to the pathology of ischemic injury. 44 Four of the genes from our focused list (Vdac2, Prkab1, Slc25a3, and G6pc) have been shown to participate in the monitoring and regulation of energetic pathways. VDAC2, in addition to its role in apoptosis, helps to regulate the ingress and egress of small metabolites, including ATP and adenosine diphosphate from the mitochondrial space. 11 Protein kinase, AMP-activated protein (Prkab1), has been shown to be involved in nutrient sensing. 55 Slc25a3 is a mitochondrial transport protein that is involved in the transport of inorganic phosphates into the mitochondrial space 56 and is therefore directly involved in regulating mitochondrial ATP production. Glucose-6-phosphatase is an endoplasmic reticulum protein that is involved in conversion of D-glucose-6-phosphate to D-glucose and inorganic phosphate in liver and kidney cortex. 57 In conclusion, we have performed a novel comparative analysis of DNA microarray data to further our understanding of how clinically relevant anesthetic exposures can lead to protection against ischemic injury. By comparing expression patterns from multiple rat-derived tissues, we have been able to generate a focused list of genes some of which may be important for delayed APC. Further functional studies will need to be performed to determine how these genes might be involved in the molecular pathways underlying anesthetic-mediated protection. E Figure 2 . Comparison of differential regulation of 3 genes by DNA microarray and by quantitative reverse-transcriptase polymerase chain reaction (QRT-PCR). The trend line represents strong agreement between DNA microarray and QRT-PCR results. The same sample of RNA was used for both experiments. Microarray values shown are the average "median of ratios" value from 9 independent arrays ± SEM. 
